By Richard Coles
27 August 2021, 8:00 AM
Tyro Payments' (ASX:TYR) FY21 result was noisy with one-off costs heavily impacting reported numbers. While the reported NPAT loss of -A$29m was comfortably below consensus, the normalised NPAT result was more in-line.
Read more...
By Richard Coles
27 August 2021, 6:00 AM
Management guided to a FY22 operating EBIT broadly in line with FY21, and low single digit revenue growth. LNK also announced a A$150m on-market share buyback.
Read more...
By Richard Coles
26 August 2021, 1:00 PM
Afterpay Touch (ASX:APT) reported an FY21 NPAT loss of ~A$159m, which was well below consensus of -A$81m, although the difference appeared largely due to some one-offs.
Read more...
By Richard Coles
26 August 2021, 11:00 AM
Medibank's (ASX:MPL) FY21 result was 1% above company-complied consensus at NPAT, with a beat in the Health Insurance (HI) business being offset in other areas.
Read more...
By Richard Coles
26 August 2021, 8:30 AM
Zip Co (ASX:Z1P) reported a FY21 NPAT loss of ~A$653m, impacted by a number of one-off non-cash items.
Read more...
By Richard Coles
24 August 2021, 8:00 AM
The key result themes, in our view, were largely as expected with a strong ARHI result offsetting some weakness in other divisions (IIHI and travel), although the 2H21 IIHI performance was weaker than expected.
Read more...
By Richard Coles
20 August 2021, 9:00 AM
Perpetual's (ASX:PPT) FY21 underlying NPAT was 4% above consensus, with revenue more broadly in-line with market expectations.
Read more...
By Richard Coles
13 August 2021, 8:00 AM
QBE Insurance Group’s (ASX:QBE) 1H21 NPAT was comfortably ahead of Factset consensus, with the 1H21 DPS also above expectations.
Read more...
By Richard Coles
12 August 2021, 7:30 AM
Insurance Australia Group's (ASX:IAG) FY21 result had been largely pre-released, however we believe some share price weakness on result day reflected top-line consumer premium and rate trends that arguably lagged its key peer SUN.
Read more...
By Richard Coles
12 August 2021, 7:00 AM
Computershare (ASX:CPU) FY21 management NPAT (US$284m) was down ~7.5% on pcp, but broadly in-line with Bloomberg Consensus (US$281m) and company guidance (-8%).
Read more...